tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Standard BioTools Inc

LAB
Add to Watchlist
0.868USD
-0.029-3.27%
Close 07-31 16:00（ET）Quotes delayed by 15 min
339.79MMarket Cap
4.34P/E TTM

Standard BioTools Inc

0.868
-0.029-3.27%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

LAB Financials

See Standard BioTools Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Standard BioTools Inc Earnings Date

Latest Release
Aug 5, 2026
EPS / Forecast
--/-0.01
Revenue / Forecast
--/20.80M
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
85.33M
-6.24%
EPS(YoY)
-0.20
62.51%
Analyst Rating
BUY
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
575.55%0.33
155.06%0.05
-25.03%-0.09
28.39%-0.09
74.10%-0.07
63.34%-0.09
72.67%-0.07
43.31%-0.12
-24.78%-0.27
5.47%-0.25
---0.27
---0.22
---0.21
---0.26
---2.17
----
----
----
----
----
Revenue
-48.17%21.15M
-49.07%23.80M
-56.52%19.55M
-41.51%21.76M
-10.42%40.80M
65.74%46.72M
77.27%44.97M
34.48%37.20M
81.30%45.54M
4.32%28.19M
-1.09%25.37M
47.34%27.67M
-5.23%25.12M
-29.38%27.02M
-10.03%25.65M
-39.46%18.78M
-19.18%26.50M
-14.22%38.27M
-28.49%28.50M
19.03%31.02M
Net Profit
588.10%127.07M
156.59%19.28M
-28.77%-34.69M
26.81%-33.46M
66.70%-26.03M
-72.29%-34.07M
-28.29%-26.94M
-168.30%-45.72M
-364.12%-78.17M
5.13%-19.78M
28.64%-21.00M
73.18%-17.04M
77.92%-16.84M
-121.07%-20.84M
-112.57%-29.43M
-270.64%-63.54M
-305.33%-76.29M
47.69%-9.43M
-130.76%-13.84M
-31.72%-17.14M
Net Margin
-8.39%-69.17%
180.10%58.42%
-170.52%-162.05%
33.91%-81.21%
9.63%-63.81%
-3.95%-72.93%
27.63%-59.90%
-99.51%-122.88%
-5.31%-70.61%
9.06%-70.16%
---82.77%
---61.59%
---67.05%
---77.14%
---238.63%
----
----
----
----
----
Gross Margin
10.51%53.48%
2.02%47.83%
-6.23%48.51%
21.88%48.84%
-8.89%48.39%
-1.05%46.89%
17.64%51.73%
-18.50%40.07%
10.04%53.11%
14.66%47.39%
--43.97%
--49.17%
--48.27%
--41.33%
--36.49%
----
----
----
----
----
Debt to assets ratio
-9.32%0.05%
7.84%0.05%
-99.32%0.06%
-99.31%0.05%
-99.27%0.05%
-99.75%0.05%
-57.45%8.10%
-57.61%7.77%
-59.64%7.07%
18.25%19.66%
--19.04%
--18.34%
--17.51%
--16.63%
--15.60%
----
----
----
----
----
Income Statement
Revenue
-48.17%21.15M
-49.07%23.80M
-56.52%19.55M
-41.51%21.76M
-10.42%40.80M
65.74%46.72M
77.27%44.97M
34.48%37.20M
81.30%45.54M
4.32%28.19M
-1.09%25.37M
47.34%27.67M
-5.23%25.12M
-29.38%27.02M
-10.03%25.65M
-39.46%18.78M
-19.18%26.50M
-14.22%38.27M
-28.49%28.50M
19.03%31.02M
Operating profit
68.92%-9.42M
26.27%-21.92M
3.42%-23.47M
43.56%-23.70M
21.79%-30.29M
-99.49%-29.74M
-38.78%-24.30M
-176.56%-41.99M
-138.57%-38.73M
9.56%-14.91M
31.63%-17.51M
56.33%-15.18M
40.97%-16.24M
-46.39%-16.48M
-30.56%-25.61M
-101.31%-34.76M
-42.36%-27.50M
33.39%-11.26M
-258.93%-19.61M
-25.81%-17.27M
Net Profit
588.10%127.07M
156.59%19.28M
-28.77%-34.69M
26.81%-33.46M
66.70%-26.03M
-72.29%-34.07M
-28.29%-26.94M
-168.30%-45.72M
-364.12%-78.17M
5.13%-19.78M
28.64%-21.00M
73.18%-17.04M
77.92%-16.84M
-121.07%-20.84M
-112.57%-29.43M
-270.64%-63.54M
-305.33%-76.29M
47.69%-9.43M
-130.76%-13.84M
-31.72%-17.14M
Balance Sheet
Current assets
51.58%521.45M
20.85%454.26M
4.15%472.44M
5.42%506.04M
-37.17%344.02M
137.58%375.88M
165.67%453.61M
162.21%480.03M
180.91%547.57M
-24.23%158.22M
-25.45%170.74M
-27.03%183.07M
166.31%194.93M
189.76%208.81M
211.74%229.02M
220.79%250.88M
-24.01%73.20M
-38.75%72.07M
-40.11%73.47M
-0.31%78.21M
Total current liabilities
-24.95%42.20M
64.37%108.31M
-10.49%107.97M
-20.83%98.02M
-53.74%56.24M
-39.73%65.89M
132.85%120.61M
164.32%123.81M
177.60%121.55M
151.66%109.33M
12.20%51.80M
9.52%46.84M
-7.18%43.79M
-12.36%43.44M
-2.37%46.17M
-19.07%42.77M
-11.87%47.17M
-8.63%49.57M
10.51%47.29M
37.81%52.85M
Total assets
10.27%639.11M
-7.28%567.75M
-20.82%539.64M
-21.41%556.97M
-25.47%579.60M
89.54%612.34M
100.88%681.54M
99.18%708.73M
109.24%777.67M
-17.23%323.07M
-18.23%339.29M
-19.34%355.83M
36.67%371.65M
41.82%390.31M
47.03%414.92M
52.47%441.12M
-10.90%271.94M
-15.26%275.21M
-12.63%282.19M
2.47%289.31M
Total liabilities
-37.61%77.99M
2.02%143.46M
-27.17%139.98M
-33.27%132.43M
-37.61%125.00M
-12.04%140.62M
20.32%192.21M
25.65%198.47M
27.16%200.35M
-0.41%159.87M
-4.00%159.75M
-5.60%157.96M
-36.93%157.55M
-11.13%160.52M
-8.99%166.41M
-6.97%167.32M
37.07%249.82M
-2.74%180.62M
6.93%182.85M
20.21%179.87M
Total equity
23.43%561.12M
-10.05%424.29M
-18.33%399.66M
-16.80%424.54M
-21.26%454.60M
189.04%471.72M
172.56%489.33M
157.88%510.26M
169.65%577.32M
-28.98%163.20M
-27.76%179.53M
-27.73%197.87M
868.21%214.10M
142.91%229.79M
150.16%248.51M
150.16%273.80M
-82.01%22.11M
-31.97%94.60M
-34.64%99.34M
-17.53%109.45M
Cash Flow Statement
Net operating income
-53.87%-46.60M
91.54%-1.19M
20.33%-22.20M
47.07%-20.67M
51.53%-30.28M
0.01%-14.06M
-144.21%-27.87M
-318.59%-39.05M
-636.31%-62.48M
26.69%-14.06M
53.63%-11.41M
68.89%-9.33M
45.57%-8.48M
-173.94%-19.18M
-159.23%-24.61M
-104.50%-29.99M
-20.84%-15.59M
-87.57%-7.00M
-106.44%-9.49M
-425.59%-14.66M
Net investment
1206.60%191.09M
-131.25%-8.04M
78.37%-6.68M
-45.27%27.50M
-95.40%14.63M
296.13%25.73M
38.14%-30.88M
25.25%50.26M
637.07%318.07M
-132.59%-13.12M
-565.03%-49.93M
129.03%40.13M
5071.66%43.15M
3614.85%40.24M
729.31%10.74M
-3213.52%-138.24M
82.37%-868.00K
-76.97%-1.15M
-112.78%-1.71M
-141.13%-4.17M
Net financing
13.04%-40.00K
101.14%620.00K
-5500.00%-112.00K
100.38%108.00K
99.77%-46.00K
-5335.69%-54.52M
99.83%-2.00K
-1260.89%-28.36M
-671.42%-19.73M
-271.48%-1.00M
-23180.00%-1.16M
-100.98%-2.08M
-114.15%-2.56M
-103.70%-270.00K
-100.05%-5.00K
160218.80%212.96M
1861.70%18.07M
2739.30%7.30M
-51.58%9.82M
-126.98%-133.00K

FAQs

What is the total revenue of Standard BioTools Inc?

According to Standard BioTools Inc's FY2025 earnings report, its total revenue reached 85.33M, with a year-on-year change of 91.01M.

What are the current assets of Standard BioTools Inc?

According to Standard BioTools Inc's FY2025 earnings report, its current assets were 454.26M, with a year-on-year change of 20.85.

What are the total assets of Standard BioTools Inc?

According to Standard BioTools Inc's FY2025 earnings report, its total assets of Standard BioTools Inc were 567.75M, with a year-on-year change of -7.28.

What are the total liabilities of Standard BioTools Inc?

According to Standard BioTools Inc's FY2025 earnings report, its total liabilities of Standard BioTools Inc were 143.46M, with a year-on-year change of 2.02.

What is the total equity of Standard BioTools Inc?

According to Standard BioTools Inc's FY2025 earnings report, its total equity of Standard BioTools Inc was 424.29M, with a year-on-year change of -10.05.

What is the net operating income of Standard BioTools Inc?

According to Standard BioTools Inc's FY2025 earnings report, its net operating income of Standard BioTools Inc was -93.31M, with a year-on-year change of -7.24.

What is the net investment of Standard BioTools Inc?

According to Standard BioTools Inc's FY2025 earnings report, its net investment of Standard BioTools Inc was 27.41M, with a year-on-year change of -92.45.

What is the net financing of Standard BioTools Inc?

According to Standard BioTools Inc's FY2025 earnings report, its net financing of Standard BioTools Inc was 570.00K, with a year-on-year change of 100.56.

What is the Earnings Per Share (EPS) of Standard BioTools Inc?

According to Standard BioTools Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.20, with a year-on-year change of 62.51.

What is the net income of Standard BioTools Inc?

According to Standard BioTools Inc's FY2025 earnings report, its net income was -74.90M, with a year-on-year change of 59.49.

What is the net margin of Standard BioTools Inc?

According to Standard BioTools Inc's FY2025 earnings report, its net profit margin was -68.94, with a year-on-year change of 31.01.

What is the gross margin of Standard BioTools Inc?

According to Standard BioTools Inc's FY2025 earnings report, its gross margin was 49.86, with a year-on-year change of 1.09.

What is the debt-to-asset ratio of Standard BioTools Inc?

According to Standard BioTools Inc's FY2025 earnings report, its debt-to-asset ratio was 0.05, with a year-on-year change of 7.84.

What is the Return on Equity (ROE) of Standard BioTools Inc?

According to Standard BioTools Inc's FY2025 earnings report, its Return on Equity (ROE) was -13.13, with a year-on-year change of 84.48.

What is the Return on Assets (ROA) of Standard BioTools Inc?

According to Standard BioTools Inc's FY2025 earnings report, its Return on Assets (ROA) was -9.97, with a year-on-year change of 48.73.

What is the operating profit of Standard BioTools Inc?

According to Standard BioTools Inc's FY2025 earnings report, its operating profit was -93.31M, with a year-on-year change of -7.24.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy